Cargando…

Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001

For a safe and sustainable environment, effective microbes as biocontrol agents are in high demand. We have isolated a new Bacillus velezensis strain DTU001, investigated its antifungal spectrum, sequenced its genome, and uncovered the production of lipopeptides in HPLC-HRMS analysis. To test the an...

Descripción completa

Detalles Bibliográficos
Autores principales: Devi, Sagarika, Kiesewalter, Heiko T., Kovács, Renátó, Frisvad, Jens Christian, Weber, Tilmann, Larsen, Thomas Ostenfeld, Kovács, Ákos T., Ding, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719288/
https://www.ncbi.nlm.nih.gov/pubmed/31508511
http://dx.doi.org/10.1016/j.synbio.2019.08.002
_version_ 1783447907325706240
author Devi, Sagarika
Kiesewalter, Heiko T.
Kovács, Renátó
Frisvad, Jens Christian
Weber, Tilmann
Larsen, Thomas Ostenfeld
Kovács, Ákos T.
Ding, Ling
author_facet Devi, Sagarika
Kiesewalter, Heiko T.
Kovács, Renátó
Frisvad, Jens Christian
Weber, Tilmann
Larsen, Thomas Ostenfeld
Kovács, Ákos T.
Ding, Ling
author_sort Devi, Sagarika
collection PubMed
description For a safe and sustainable environment, effective microbes as biocontrol agents are in high demand. We have isolated a new Bacillus velezensis strain DTU001, investigated its antifungal spectrum, sequenced its genome, and uncovered the production of lipopeptides in HPLC-HRMS analysis. To test the antifungal efficacy, extracts of B. velezensis DTU001 was tested against a range of twenty human or plant pathogenic fungi. We demonstrate that inhibitory potential of B. velezensis DTU001 against selected fungi is superior in comparison to single lipopeptide, either iturin or fengycin. The isolate showed analogous biofilm formation to other closely related Bacilli. To further support the biocontrol properties of the isolate, coculture with Candida albicans demonstrated that B. velezensis DTU001 exhibited excellent antiproliferation effect against C. albicans. In summary, the described isolate is a potential antifungal agent with a broad antifungal spectrum that might assist our aims to avoid hazardous pathogenic fungi and provide alternative to toxicity caused by chemicals.
format Online
Article
Text
id pubmed-6719288
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-67192882019-09-10 Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001 Devi, Sagarika Kiesewalter, Heiko T. Kovács, Renátó Frisvad, Jens Christian Weber, Tilmann Larsen, Thomas Ostenfeld Kovács, Ákos T. Ding, Ling Synth Syst Biotechnol Article For a safe and sustainable environment, effective microbes as biocontrol agents are in high demand. We have isolated a new Bacillus velezensis strain DTU001, investigated its antifungal spectrum, sequenced its genome, and uncovered the production of lipopeptides in HPLC-HRMS analysis. To test the antifungal efficacy, extracts of B. velezensis DTU001 was tested against a range of twenty human or plant pathogenic fungi. We demonstrate that inhibitory potential of B. velezensis DTU001 against selected fungi is superior in comparison to single lipopeptide, either iturin or fengycin. The isolate showed analogous biofilm formation to other closely related Bacilli. To further support the biocontrol properties of the isolate, coculture with Candida albicans demonstrated that B. velezensis DTU001 exhibited excellent antiproliferation effect against C. albicans. In summary, the described isolate is a potential antifungal agent with a broad antifungal spectrum that might assist our aims to avoid hazardous pathogenic fungi and provide alternative to toxicity caused by chemicals. KeAi Publishing 2019-08-27 /pmc/articles/PMC6719288/ /pubmed/31508511 http://dx.doi.org/10.1016/j.synbio.2019.08.002 Text en © 2019 Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Devi, Sagarika
Kiesewalter, Heiko T.
Kovács, Renátó
Frisvad, Jens Christian
Weber, Tilmann
Larsen, Thomas Ostenfeld
Kovács, Ákos T.
Ding, Ling
Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001
title Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001
title_full Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001
title_fullStr Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001
title_full_unstemmed Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001
title_short Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001
title_sort depiction of secondary metabolites and antifungal activity of bacillus velezensis dtu001
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719288/
https://www.ncbi.nlm.nih.gov/pubmed/31508511
http://dx.doi.org/10.1016/j.synbio.2019.08.002
work_keys_str_mv AT devisagarika depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001
AT kiesewalterheikot depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001
AT kovacsrenato depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001
AT frisvadjenschristian depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001
AT webertilmann depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001
AT larsenthomasostenfeld depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001
AT kovacsakost depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001
AT dingling depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001